Alcon Inc., CH0432492467

BTIG cuts Alcon target to USD 74 and Alcon stock trades at EUR 58.49

Published on 10/13/2026 at 10:02 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

For Alcon stock, Q2 revenue reached USD 2.82 billion and earnings per share USD 0.84. Next earnings are scheduled for November 10, 2026, with consensus at USD 0.89.

Key points in brief

  • BTIG lowered its Alcon price target from USD 82.00 to USD 74.00 on October 12, 2026, while keeping a Buy rating.
  • Alcon reported Q2 2026 revenue of USD 2.82 billion and earnings per share of USD 0.84 against a USD 0.77 consensus estimate.
  • Alcon stock was at EUR 58.49 at Lang & Schwarz on October 13, 2026 at 9:59 a.m. CEST.
  • The next earnings release is scheduled for November 10, 2026, with consensus earnings per share of USD 0.89.
Flat lay product photography on white marble. Contact lens case, lens solution bottle, soaking dish, and optometry trial lens kit arranged neatly with soft studio overhead lighting, clinical cleanliness, no text on items
Alcon CH0432492467: Flatlay mit Kontaktlinsenbehälter, Pflegelösung und Probierlinsen Set auf weißem Marmor, Illustration mit AI erstellt.

Alcon stock was at EUR 58.49 at Lang & Schwarz on October 13, 2026 at 9:59 a.m. CEST, while BTIG had cut its target from USD 82.00 to USD 74.00 on October 12, 2026, according to Markets Insider. The analyst kept a Buy rating while previewing Alcon's third-quarter results.

Three milestones shape the setup

On August 10, 2026, Alcon reported USD 2.82 billion in second-quarter revenue and earnings per share of USD 0.84, above the USD 0.77 consensus estimate, according to MarketBeat.

On October 7, 2026, Barclays initiated coverage with an Equal Weight rating and a USD 70.00 price target, as reported by Yahoo Finance.

On October 12, 2026, BTIG lowered its target from USD 82.00 to USD 74.00 and retained its Buy rating, according to Markets Insider. The sequence puts the upcoming report at the center of the stock's near-term valuation debate.

What does the target cut change?

BTIG's move contrasts with the strong second-quarter comparison: actual earnings per share of USD 0.84 exceeded the USD 0.77 estimate, while revenue reached USD 2.82 billion. The lower target signals that the market is weighing that result against tougher comparisons and the earnings outlook for the rest of 2026.

November results are next

Alcon's next earnings release is scheduled for November 10, 2026, with consensus earnings per share of USD 0.89 for the quarter ending September 2026, according to Zacks. That estimate gives investors a concrete benchmark after the USD 0.84 result in the second quarter.

Swiss listing and market value

Alcon is listed on SIX under ticker ALC.SW. Yahoo Finance showed a CHF 47.80 to CHF 68.34 52-week range and a CHF 53.14 close on October 9, 2026, while the finance quote showed market capitalization of USD 31.4 billion as of October 12, 2026. The Lang & Schwarz price is stated separately in euros and is not combined with the Swiss-franc quotation.

Price stays the live reference

At Lang & Schwarz, Alcon was trading at EUR 58.49 on October 13, 2026 at 9:59 a.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Alcon stock.

Alcon stock facts

  • Company: Alcon Inc.
  • ISIN: CH0432492467
  • Ticker: ALC.SW
  • Primary exchange: SIX
  • Price Lang & Schwarz (as of October 13, 2026, 9:59 a.m. CEST): EUR 58.49
  • Market capitalization: USD 31.4 billion (as of October 12, 2026)
  • 52-week range: CHF 47.80-CHF 68.34 (as of October 9, 2026)
  • Sector / Industry: Health Care / Medical Instruments and Supplies
  • Next earnings date: November 10, 2026

Market context: Market report SMI.

More news and analyses on Alcon stock

Disclaimer...

en | CH0432492467 | ALCON INC. | boerse | 70311627 | bgmi